The WHO Global Tuberculosis 2021 Report - not so good news and turning the tide back to End TB.
Jeremiah Chakaya, Eskild Petersen, Rebecca Nantanda...
https://pubmed.ncbi.nlm.nih.gov/35321845/Actively Recruiting
Led by University of Cologne · Updated on 2025-03-13
150
Participants Needed
6
Research Sites
N/A
Total Duration
Researchers are investigating extrapulmonary tuberculosis EPTB, a form of tuberculosis that affects organs other than the lungs. This observational study involves adults newly diagnosed with EPTB and aims to improve clinical management by developing specific biomarkers for diagnosis and treatment monitoring. The study also includes pulmonary TB patients and healthy controls to support laboratory analyses and comparisons. The research is conducted across multiple centers in Germany, addressing the rising proportion of EPTB cases and challenges in treatment evaluation. Participants receive standard clinical care while clinical data and biological samples such as blood and urine are collected throughout their treatment. The study has several groups based on the extent of sample collection, including patients with full and partial samples and healthy controls. Data collection points occur at diagnosis, during treatment at 4 weeks, 3 months, and 6 months, and after treatment completion, with additional follow-up for longer treatments. Biomarker analyses include gene expression and T-cell assays, with samples stored centrally for detailed laboratory studies. During study visits, routine clinical assessments such as symptom evaluation, laboratory tests, and imaging ultrasound, CT, MRI are performed. Researchers collect sputum and urine samples for microbiological testing and gather data using case report forms transferred to an electronic database. Outcomes focus on blood biomarkers for diagnosis and treatment response, correlated with clinical signs like symptom improvement and weight gain. This comprehensive approach aims to better predict treatment success and guide future EPTB care strategies over a two-year period.
CONDITIONS
A Multicentric Cohort and Biomarker Study for Improved Care of Patients with Extrapulmonary Tuberculosis
I
Isabelle Suarez, Dr
A
Angela Klingmüller, Dr
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Cologne
Lead Sponsor
University Hospital, Bonn
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 2 years
Participants with extrapulmonary tuberculosis will have routine clinical and laboratory parameters, radiographic imaging, and microbiology specimens collected. Additional blood and urine samples will be collected at multiple time points to assess biomarkers related to diagnosis and treatment response.
Visits at diagnosis/treatment initiation, 4 weeks, 3 months, 6 months post treatment initiation, and 3 months post end of treatment; additional visits if treatment extends beyond 6 months
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jeremiah Chakaya, Eskild Petersen, Rebecca Nantanda...
https://pubmed.ncbi.nlm.nih.gov/35321845/Tom Schaberg, Torsten Bauer, Folke Brinkmann...
https://pubmed.ncbi.nlm.nih.gov/28651293/Stefanie Warnat-Herresthal, Hartmut Schultze, Krishnaprasad Lingadahalli Shastry...
https://pubmed.ncbi.nlm.nih.gov/34040261/J Fortún, P Martín-Dávila, E Gómez-Mampaso...
https://pubmed.ncbi.nlm.nih.gov/24670706/Adane Mihret, Yonas Bekele, Kidest Bobosha...
https://pubmed.ncbi.nlm.nih.gov/23178506/Jessica Gräb, Isabelle Suárez, Edeltraud van Gumpel...
https://pubmed.ncbi.nlm.nih.gov/30737374/Andrés González-García, Jesús Fortún, Enrique Elorza Navas...
https://pubmed.ncbi.nlm.nih.gov/28658113/Isabelle Suárez, Sarah Maria Fünger, Norma Jung...
https://pubmed.ncbi.nlm.nih.gov/31182290/Stephen M Graham, Luis E Cuevas, Patrick Jean-Philippe...
https://pubmed.ncbi.nlm.nih.gov/26409281/G Paul, J Wesselmann, D Adzic...
https://pubmed.ncbi.nlm.nih.gov/33128333/University of Cologne
Lead Sponsor
University Hospital, Bonn
Collaborating Sponsor